Zai Lab Ltd.
(NASDAQ : ZLAB)

( )
ZLAB After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -5.21%161.910.0%$1387.78m
NVAXNovavax, Inc. -2.57%221.5080.0%$650.79m
AMGNAmgen, Inc. 0.10%255.971.3%$554.37m
SNSSSunesis Pharmaceuticals, Inc. -5.63%7.550.7%$527.77m
ILMNIllumina, Inc. 1.30%404.183.5%$527.33m
REGNRegeneron Pharmaceuticals, Inc. -0.58%499.692.7%$447.00m
GILDGilead Sciences, Inc. -1.38%65.951.0%$437.06m
VRTXVertex Pharmaceuticals, Inc. -0.10%219.181.9%$383.57m
ALXNAlexion Pharmaceuticals, Inc. 1.09%165.472.0%$360.29m
BNTXBioNTech SE -1.36%149.480.0%$336.51m
BIIBBiogen, Inc. -0.47%269.051.7%$246.78m
NBIXNeurocrine Biosciences, Inc. -1.79%94.854.9%$180.78m
EXASEXACT Sciences Corp. -1.93%127.5318.4%$168.47m
CRSPCRISPR Therapeutics AG -2.97%115.040.6%$158.56m
SGENSeagen Inc. -1.02%144.015.8%$140.14m

Company Profile

Zai Lab Ltd. is a biopharmaceutical company. It engages in the discovering, licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need in the fields of oncology, infectious, and autoimmune diseases. The firm's products include Zejula and Optune. The company was founded by Samantha Ying Du and Marietta Wu in April 2014 and is headquartered in Shanghai, China.